# Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis

> **NCT02908334** · PHASE2 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Coccidioidomycosis

## Interventions

- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT02908334
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-11
- **Primary completion:** 2019-01-22
- **Final completion:** 2019-01-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** failure to enroll
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02908334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02908334, "Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02908334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*